Patient assistance programs (PAPs) are programs created by drug companies, such as JOHNSON & JOHNSON PATIENT ASSISTANCE FOUNDATION, to offer free or low cost drugs to individuals who are unable to pay for their medication. These Programs may also be called indigent drug programs, charitable drug programs or medication assistance programs. Most of the best known and most prescribed drugs can be found in these programs. All of the major drug companies have patient assistance programs, although every company has different eligibility and application requirements.
The JOHNSON & JOHNSON PATIENT ASSISTANCE FOUNDATION patient assistance program offers free medication to people who otherwise cannot afford their medications. Patients must meet financial and other program specific criteria to be eligible for assistance.
To find out how to apply for medication assistance from the JOHNSON & JOHNSON PATIENT ASSISTANCE FOUNDATION patient assistance program, visit our Patient Center and use our Database to search for the medication needed.
For a complete listing of JOHNSON & JOHNSON PATIENT ASSISTANCE FOUNDATION medications available through their patient assistance programs, see below:
J&J Hospital Access Patient Assistance Program | |
| The medications available through this program are: | |
Invokamet (canagliflozin-metformin) | |
Invokamet XR (canagliflozin/metformin HCI) | |
Prezcobix Tablets (darunavir/cobicistat) | |
Symtuza (darunavir, cobicistat, emtricitabine, and tenofovir alafenamide) | |
Xarelto (rivaroxaban tablets) |
Johnson & Johnson Patient Assistance Program
The medications available through this program are:Darzelex Faspro (daratumumab and hyaluronidase-fihj, Injection for subcutaneous use)
Elmiron (pentosan polysulfate sodium)
Erleada Tablets (apalutamide)
Infliximab Intravenous Infusion (Infliximab Intravenous Infusion)
Invega Hafyera (paliperidone palmitate)
Invega Sustenna (paliperidone palmitate)
Invega Trinza (paliperidone palmitate)
Invokamet (canagliflozin-metformin)
Invokamet XR (canagliflozin/metformin HCI)
Monovisc (sodium hyaluronate)
Ponvory (ponesimod tablets)
Prezcobix Tablets (darunavir/cobicistat)
Risperdal Consta (risperidone)
Rybrevant (amivantamab-vmjw)
Simponi ARIA Injection (golimumab)
Sirturo Tablets (bedaquiline)
Symtuza (darunavir, cobicistat, emtricitabine, and tenofovir alafenamide)
Xarelto (rivaroxaban tablets)
PAH Medications - Johnson & Johnson Patient Assistance Program
The medications available through this program are:Opsumit Tablet (macitentan)
Tracleer tablets (bosentan)
Veletri Injection (epoprostenol)